You are here

Home

Cancer/Tumor

DSTHO

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Existing treatments of human cancer, which is characterized by abnormal proliferation of cells often lead to fatal outcomes. Sequence selective silencing of oncogene expression using siRNA technology is emerging as a potential solution for cancer treatment. The exclusive selectivity and easy application to virtually any therapeutic target including intracellular factors and transcription factors renders siRNA oligonucleotide applications very promising. However, synthesis of siRNA having sufficient knockdown efficiency is laborious and cost intensive.

Rating: 
Average: 5 (1 vote)

HCCNet

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Abstract is not available.[1]

 

 

 

 

 

Rating: 
Average: 5 (1 vote)

LiverCancerMarkerRIF

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Biomarkers are biomolecules in the human body that can indicate disease states and abnormal biological processes. Biomarkers are often used during clinical trials to identify patients with cancers. Although biomedical research related to biomarkers has increased over the years and substantial effort has been expended to obtain results in these studies, the specific results obtained often contain ambiguities, and the results might contradict each other.

Rating: 
Average: 5 (1 vote)

miR_Path

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

MicroRNAs (miRNAs) are short non-coding RNAs that play important roles in post-transcriptional regulations as well as other important biological processes. Recently, accumulating evidences indicate that miRNAs are extensively involved in cancer. However, it is a big challenge to identify which miRNAs are related to which cancer considering the complex processes involved in tumors, where one miRNA may target hundreds or even thousands of genes and one gene may regulate multiple miRNAs.

Rating: 
Average: 5 (1 vote)

msgl

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Contamination of a cancer tissue by the surrounding benign (non-cancerous) tissue is a concern for molecular cancer diagnostics. This is because an observed molecular signature will be distorted by the surrounding benign tissue, possibly leading to an incorrect diagnosis. One example is molecular identification of the primary tumor site of metastases because biopsies of metastases typically contain a significant amount of benign tissue.

Rating: 
Average: 5 (1 vote)

mirnanalyze

Submitted by ChenLiang on Thu, 04/06/2017 - 19:32

The current state-of-the-art in cancer diagnosis and treatment is not ideal; diagnostic tests are accurate but invasive, and treatments are "one-size fits-all" instead of being personalized. Recently, miRNA's have garnered significant attention as cancer biomarkers, owing to their ease of access (circulating miRNA in the blood) and stability. There have been many studies showing the effectiveness of miRNA data in diagnosing specific cancer types, but few studies explore the role of miRNA in predicting treatment outcome.

Rating: 
Average: 5 (1 vote)

FMIGS

Submitted by ChenLiang on Sun, 09/10/2017 - 17:05

MicroRNAs (miRNA) are one of the important regulators of cell division and also responsible for cancer development. Among the discovered miRNAs, not all are important for cancer detection. In this regard a fuzzy mutual information (FMI) based grouping and miRNA selection method (FMIGS) is developed to identify the miRNAs responsible for a particular cancer. First, the miRNAs are ranked and divided into several groups. Then the most important group is selected among the generated groups.

Rating: 
Average: 5 (1 vote)

G-DOC

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Approximately 80% of Stage II colon cancer patients are cured by appropriate surgery. However, 20% relapse, and virtually all of these people will die due to metastatic disease. Adjuvant chemotherapy has little or no impact on relapse or survival in Stage II colon cancer, and can only add toxicity without benefit for 80% of the target population that has been cured by surgery.

Rating: 
Average: 5 (1 vote)

dbPHCC

Submitted by ChenLiang on Fri, 09/02/2016 - 21:59

Hepatocellular carcinoma (HCC) is one of the most common malignant cancers with a poor prognosis. For decades, more and more biomarkers were found to effect on HCC prognosis, but these studies were scattered and there were no unified identifiers. Therefore, we built the database of prognostic biomarkers and models for hepatocellular carcinoma (dbPHCC).

Rating: 
5
Average: 4.5 (2 votes)

ParSel

Submitted by ChenLiang on Sun, 09/10/2017 - 20:04

It is known that tumor micro-RNAs (miRNA) can define patient survival and treatment response. We present a framework to identify miRNAs which are predictive of cancer survival. The framework attempts to rank the miRNAs by exploring their collaborative role in gene regulation. Our approach tests a significantly large number of combinatorial cases leveraging parallel computation. We carefully avoided parametric assumptions involved in evaluations of miRNA expressions but used rigorous statistical computation to assign an importance score to a miRNA.

Rating: 
Average: 5 (1 vote)

Pages

Subscribe to Cancer/Tumor